The preparation of infectious beak and feather disease circovirus virions (BFDV) has until now relied on the extraction of virus from whole tissue of deceased or euthanized parrots known to be infected with the virus. Extraction from diseased tissue is necessary, as the virus has yet to be grown in vitro using tissue-cultured cells from any source. While infectious DNA clones have been synthesized for porcine and duck circoviruses, and both replicate in host cells and result in active viral infection in animals, this has not been shown for BFDV. The aim of this study was to prepare an infectious BFDV genomic clone that could be used as challenge material in birds for vaccine testing. A putatively infectious BFDV genomic clone was designed and tested in mammalian cell culture, and in the plant Nicotiana benthamiana in the presence of plantspecific ssDNA geminivirus replication components. Replication was assessed using rolling-circle amplification, qPCR, replication-deficient clones and rescue plasmids. We showed that a synthetic partially dimeric BFDV genomic clone selfreplicated when transfected into 293TT mammalian cells, and was also replicated in N. benthamiana in the presence of geminivirus replication elements. This is the first report of a BFDV genome replicating in any cell system, and the first report of a circovirus replicating with the aid of a geminivirus in a plant. Both of these developments could open up possibilities for making reagents and vaccines for BFDV, testing vaccine efficacy and investigating viral replication using rationally designed artificial genomes.
INTRODUCTION
In order for the efficacy of an animal viral vaccine to be established, the vaccine should be tested in a live infectious virus challenge trial [1] . For beak and feather disease virus (BFDV), which is possibly the worst viral pathogen of psittacines, infectious virus must be purified from whole tissue of deceased or euthanized parrots known to be infected with the virus, as the virus has yet to be grown in vitro using tissue culture of any sort [2] . Difficulties in culturing the virus have been attributed to tissue specificity and in vitro growth requirements [3] . Similar problems have been reported for other avian circoviruses, such as goose and pigeon circoviruses [4, 5] . Recently, however, duck circovirus (DuCV) has been shown to replicate -albeit with low efficiency -in continuous cell lines derived from Muscovy ducks (Cairina moschata) [6] . Research advances for circovirus vaccines have therefore mainly been made only for the economically important and culturable porcine circoviruses (PCV), while developments with avian circoviruses have lagged considerably behind.
PCV-1 was first described as a tissue culture contaminant in porcine kidney 15 (PK-15) cells, and has since been extensively studied. Infectious genomic clones of the non-pathogenic PCV-1 and the related pathogenic PCV-2 have been synthesized and tested successfully in tissue culture [7] . Recircularized full-length PCV-2 dsDNA genomes have been shown to produce virus particles in both foetal porcine retina cell line (VIDO R1) and PK-15 cells [8, 9] . In addition, infectious PCV-2 clones have been used to produce active infections in pigs through direct injection into the liver and lymph nodes [10] . The ability to uncouple viral replication and virion production has enabled researchers to create PCV1-2 chimeras that produce immunity against PCV-2 but are attenuated in pigs [11, 12] . Furthermore, chimaeric viruses have been created with PCV-2 subtypes that are then capable of eliciting protective immunity against both dominant and emerging subtypes [13] . Thus far, infectious genomic clones of PCV have been used successfully in pigs to establish an infection during challenge, and porcine cell lines have been used to produce infectious virus particles [8] [9] [10] . Infectious clones have also been made successfully for DuCV, and if the same could be done for BFDV, this would circumvent the difficulties associated with virus purification from birds [10, 14] .
The BFDV genome, like those of the PCVs and DuCV, is a circular ssDNA molecule approximately 2 kb in size [15] that only encodes the replication-associated protein (Rep) and capsid protein (CP) (Fig. 1a ) [16] . Rolling-circle replication (RCR) of BFDV is dependent on the interaction of the Rep and the origin of replication (ori), which contains a nonanucleotide (N9) motif (5¢-TAGTATTAC-3¢) displayed on a stem-loop [16, 17] . It has been shown in PCV that the Rep nicks the genome-sense DNA in dsDNA replicative intermediates within the N9 motif as shown (5¢-TAAGTATT/AC-3¢) to initiate RCR [17] . An infectious BFDV genomic clone would therefore comprise a partially dimeric genome with the ori sequence repeated, cloned into a theta-replicating plasmid. Successful release of the circular monomeric BFDV DNA genome or replicon from the plasmid can be detected conveniently using isothermal phi29 polymerase-mediated rolling-circle DNA amplification (RCA). The technique enriches for circular DNA compared to linear DNA templates, and the amplification products can be treated with restriction endonucleases and separated using gel electrophoresis to detect the input plasmid DNA as well as the released BFDV genomic DNA. Johne et al. [18] reviewed the use of RCA as applied to circular viral DNA genomes in detail.
The benefits of using an infectious genomic clone for BFDV challenge experiments would be the ease and reproducibility of producing purified DNA, simple spectrophotometric quantification and infection of animals by direct injection of DNA. In contrast, at present virus stocks of BFDV can only be purified from diseased animal tissue, and the assay of purified infectious virus requires titrations of it in animals -via LD 50 or ID 50 determinations -in order to calculate the viral titre [10] . Pure BFDV virus isolates could also potentially be produced in birds using infectious clones as starting material, thus ensuring that viral preparations are free of other pathogens.
As no continuous psittacine cell lines exist, and no other cell cultures are known to support infection or replication, an infectious BFDV genomic clone would require in vitro testing in embryonated psittacine eggs or possibly an alternative system. Cheung [17] demonstrated that the PCV genome could self-replicate in E. coli, suggesting that the BFDV genome could also potentially replicate outside of the virus's avian host cells, especially if introduced as DNA in order to circumvent host cell recognition limitations. The mechanism of replication for geminiviruses, plant viruses with circular ssDNA genomes, is essentially identical to the RCR in circoviruses, as described above. Our laboratory created a replicating plant expression system based on the ssDNA mastrevirus bean yellow dwarf virus (BeYDV), which is capable of significantly amplifying both the gene copy number and the expression of heterologous genes in Nicotiana benthamiana [19] . The leaves of N. benthamiana are routinely used to produce plant-made pharmaceuticals such as candidate vaccines, and amplification of the gene copy number has proven to be useful in increasing recombinant protein yields [19, 20] . Considering that the replication strategies of BeYDV and BFDV are very similar, we hypothesized that BeYDV might be capable of assisting the replication of BFDV in planta. The aim of this study was to design an infectious BFDV genomic clone and determine whether it can replicate in mammalian cell culture and N. benthamiana plants. A partially dimeric BFDV genomic clone was designed, and its potential for replication in mammalian cell culture was investigated using RCA, qPCR, replication-deficient clones and rescue plasmids encoding Rep. Replication of the BFDV clone was also assessed using RCA and qPCR after its introduction into N. benthamiana plants in the presence of BeYDV-derived replication components.
RESULTS
Replication of a BFDV genomic clone in 293TT cells A BFDV genomic clone consisting of a single copy of the linearized genome with an extra ori sequence was designed and synthesized (Fig. 1) . The clone was based on isolate BKS1ZA_84 (GenBank accession number GQ165756) that had previously been described in our laboratory by Varsani et al. [21] . The isolate originated from a budgerigar (Melopsittacus undulatus) and was chosen because the challenge model would probably be budgerigars due to cost considerations. To determine whether the clone could produce a viral genome or replicon in cultured mammalian cells, endotoxin-free DNA was used to transfect the HEK 293TT cells and Hela S3 cells that were available in our laboratory (data not shown). The genomic clone was transfected alongside a clone containing the BFDV cp only as a negative control. Total DNA from 293TT cells extracted on days 0 and 3 after transfection was analysed using RCA and qPCR. Amplified DNA produced during RCA was digested with BamHIwhich would produce linear 2 kb fragments containing the whole genome from BFDV genomic concatemers -and resolved using gel electrophoresis. The success of the RCA reaction was confirmed by the presence of a linear 2.7 kb dsDNA fragment for the pUC19 plasmid control DNA (Fig. 2a) . A 2 kb RCA product was absent on day 0 and present on day 3 for the BFDV genomic clone (Fig. 2a) . The presumptively linearized BFDV genome was then cloned, sequenced and confirmed to be identical in sequence to the monomeric genome sequence in the input DNA. A linear 2 kb fragment was absent on both day 0 and day 3 for the replication-negative control (Fig. 2a) . Analysis of cell samples using qPCR confirmed that there was a significant increase in the copy number of the cp from day 0 to day 3 for the BFDV clone (Fig. 2b) , and a significant decrease in the copy number of the cp from day 0 to day 3 for the replication-negative control DNA.
To confirm that the 2 kb DNA amplified using RCA and the increase in cp copy number observed by qPCR resulted from the liberation of a monomeric BFDV genome from the parent construct, two mutants of the synthesized BFDV genomic clone were created (Fig. 1) . A rep-mutant was created with the start codon of the rep gene disrupted, which would prevent Rep translation as the next in-frame ATG start codon is situated more than 200 bp downstream, meaning that the motifs I and II, which are crucial for RCR, would not be included in a possible truncated translation product [15] . An ori mutant was created in which the N9 motif within the stem-loop of the first ori was disrupted (TAGTATTAC fi TAGGATCCG; Fig. 3 ). The mutation in the ori would prevent DNA nicking by Rep, which would thereby prevent replication initiation and replicon formation. Endotoxin-free DNA was prepared for the mutants and used to transfect 293TT cells. Total DNA from cells extracted on days 0 and 3 after transfection were analysed using RCA. Amplified DNA was cut with BamHI and resolved using gel electrophoresis (Fig. 2c) . The 2 kb fragment representing the full-length BFDV genome was absent on day 0 and present on day 3 for the BFDV genomic clone (Fig. 2c) . A linear 2 kb fragment was absent on both day 0 and day 3 for the negative control and for the rep-and ori mutants. To further demonstrate that the BFDV Rep protein was responsible for initiating RCR in 293TT cells, the repmutant was transfected together with a mammalian expression 'rescue' vector expressing BFDV Rep in trans. The restoration of RCR was confirmed using RCA on total DNA from cells extracted on day 2 ( Fig. 2d) . A linear 2 kb fragment presumed to be a BFDV full-length genome was present on day 2 for the BFDV genomic clone ( Fig. 2d ) and absent for transfections with both the rep-mutant only and the mammalian expression vector containing BFDV rep only. Upon co-transfection of the rep-mutant and the functional rep in trans, a linear 2 kb presumptive BFDV genome was clearly present. Although not quantitative, it would appear that there was more of the 2 kb fragment present when the Rep was supplied in trans.
BeYDV-assisted replication of a BFDV molecular DNA clone in N. benthamiana To determine whether the BFDV genomic clone was capable of replicating in N. benthamiana, the sequence was inserted into a plant shuttle vector and Agrobacterium-infiltrated into plant leaves in the presence or absence of a BeYDV genome-derived replicating vector that expresses BeYDV Rep and contains a repeated BeYDV ori sequence. Total DNA from leaf tissue was extracted on days 1-4 after infiltration and analysed using qPCR (Fig. 4a) . In the absence of the BeYDV vector, the BFDV cp copy number remained constant over the 4-day period. In the presence of the BeYDV-derived vector, the BFDV cp increased by two orders of magnitude from day 1 to day 3, after which the copy number remained constant. Interestingly, when the BFDV ori mutant clone was similarly co-infiltrated with the BeYDV-derived vector into N. benthamiana, no difference in cp copy number was determined by qPCR between the ori mutant and the replication-competent clone, indicating that this clone too was trans-replicated by BeYDV Rep (Fig. 4b) . Unfortunately, it was not possible to confirm replicon formation by RCA for either BFDV construct, as no 2 kb linear fragment was detected after RCA for the BFDV DNA clone agroinfiltrated alone or when co-infiltrated with the BeYDV replicating vector, while a 2.5 kb fragment typical of a BeYDV replicon was detected in all plants infiltrated with the BeYDV vector (Fig. 5a ).
To check that the qPCR results for BFDV cp were due to the presence of BFDV replicons, the BFDV cp gene was cloned into the BeYDV replicating vector. The copy numbers for both the BFDV and the BeYDV replicons were then determined using BFDV cp-and rep-specific qPCR. The BFDV genomic clone was co-infiltrated into plant leaves in the presence of either an empty BeYDV replicating vector or one containing a copy of the BFDV cp. Total DNA from leaf tissue was extracted on days 1 and 4 after infiltration. The total DNA was analysed using qPCR to determine the gene copy number of rep for the BFDV genome, and cp for both the BFDV genome and the BeYDV replicon containing cp (Fig. 5b, c) . PCR analysis using primers specific for the cp indicated an increase in gene copy number from day 1 to day 4 for both infiltrations (Fig. 5b) . The cp copy number increased by over an order of magnitude when the BFDV genomic clone was infiltrated alongside an empty BeYDV replicating vector. However, when co-infiltrated with the BeYDV vector containing a BFDV cp, the BFDV cp copy number increased by three orders of magnitude. Analysis of the BFDV rep copy number, which is only reflective of BFDV replicon presence, served as a measure of BFDV genome replication in both infiltrations (Fig. 5c ). Interestingly, an approximately 10-fold decrease in BFDV rep copy number was seen when the BFDV genomic clone was coinfiltrated with the BeYDV replicating vector containing a BFDV cp, compared to coinfiltration with an empty BeYDV replicating vector on day 4 (P<0.01).
DISCUSSION Replication of a BFDV genomic clone in 293TT cells
The non-culturability of BFDV has been a significant problem for both the development of vaccines against the virus and for testing the efficacy of candidate vaccines. To circumvent the many disadvantages inherent in using BFDV virions purified from infected parrot tissue as the only source of either infectious material or material for the preparation of inactivated vaccines, a synthetic BFDV genomic clone comprising a partially dimeric genome with two ori regions was synthesized and cloned in E. coli. We then tested its potential for replication in mammalian tissue culture in cells available in our laboratory, given that purified virus has never been shown to be infectious in vitro, and no infectious genomic clone of BFDV has yet been described. We reasoned that use of a replicongenerating genomic clone might extend the tissue culture host range of the virus, given that no virion maturation or cell recognition was required. Accordingly, we tested the transfection of human-derived 293TT cells with purified DNA, and this resulted in the amplification by RCA of presumptive singlegenome sized DNA after 3 days, and an approximately 10-fold increase in BFDV-specific DNA copy number by qPCR analysis (Fig. 2) . While the 10-fold increase is modest in comparison to the viraemia seen in psittacines infected with purified virus, where viral load can increase by six orders of magnitude over a 2-week period [22] , our results represent the first proof of BFDV genome replication in any tissue culture system.
The low replication efficiency in the mammalian cell culture system could be attributed to the cell type used, given that mammalian cells are not the natural host for BFDV and could be lacking certain Rep-cofactor interactions supportive of replication. Without experimental data on the expression of CP in 293TT cells, we speculate that the virus would also most probably not be able to spread efficiently from cell to cell [2] due to a lack of appropriate receptors, which could also explain the modest increase in genome copy number.
To confirm that the increase in genome or replicon copy number was driven by the synthetic BFDV genomic clone, the clone was mutated to prevent either the translation of the BFDV rep (rep-mutant) or the initiation of replication by Rep at the N9 motif situated on the genome sense strand stem-loop (by changing (5¢-TAGTATTAC-3¢ fi TAG-GATCCG; ori mutant). The modification of the N9 motif was based on work by Cheung [23] , who performed a series of single-site mutations along the N9 motif of PCV-2 and determined that it was essential for virus replication. Transfection of the two mutants into 293TT cells failed to produce a 2 kb circular DNA similar to that shown for the native BFDV genomic clone; however, the rep-mutant generated a replicon when supplied with Rep in trans by a mammalian expression vector. The observation that more 2 kb DNA was produced when the Rep was provided in trans might have been because the Rep was being expressed from a strong promoter on the mammalian expression vector, whereas the rep promoter on the wild-type genome was relatively weak. This is the first experimental confirmation that Rep and the N9 sequence are both required in BFDV for successful initiation of replication. BeYDV-assisted replication of a BFDV molecular DNA clone in N. benthamiana We previously showed that a replicating expression vector derived from the geminivirus BeYDV could be used successfully for the amplification of heterologous genes in plants [19] ; we reported that the transgene copy number increased by three orders of magnitude over a 3-day period as the vector replicated, compared to non-replicating controls. Given that our laboratory has since successfully used the BeYDV replicon system to produce human papillomavirus (HPV) type 16 pseudovirions in N. benthamiana that are infectious in cultured mammalian cells, we decided to test the viability of the synthetic BFDV DNA clone in N. benthamiana. The reasoning was that this could provide an alternative system for replicating BFDV, and ultimately also for producing infectious virions or pseudovirions, as in the HPV-16 case [24] .
We were able to show that, while the BFDV DNA clone was unable to replicate on its own after Agrobacterium-mediated transfer into plant cells, a significant increase in genome copy number over a 4-day period was seen in the presence of the replicating BeYDV-derived plant expression vector. The BFDV-alone result was not unexpected, considering that the promoters in the BFDV genome have evolved for an avian host, and animal promoters generally do not work well in plants, and vice versa. The BFDV result, together with BeYDV result, however, indicated that the BeYDV Rep was able to successfully initiate replication of the BFDV genome. This was not too surprising, as the N9 nicking motif for geminiviruses is 5¢-TAATATTAC-3¢, while for BFDV it is 5¢-TAGTATTAC-3¢ -and it has been shown for PCV-2 (5¢-AAGTATTAC-3¢) that the nucleotide in position three (underlined) does not influence replication efficiency [23, 25] .
The positive amplification seen with the BFDV ori mutant construct was not expected given that the mutation of the first flanking ori (TAGTATTAC fi TAGGATCCG) eliminated self-replication of the construct in mammalian cells. A possible explanation for the recognition is that the changes to the BFDV sequence were based on mutations observed to be lethal in PCV-2, and did not account for allowed variations in the N9 motif of geminiviruses [23] . For example, Laufs et al. [25] demonstrated that changing the N9 motif for geminiviruses at position 7 or 8 (5¢-TAA-TATTAC-3¢) resulted in replication efficiencies that remained above 50 %; however, mutations at position 9 reduced replication efficiency to below 25 %. It could be suggested the changes to the BFDV N9 motif in this studywhich were in positions 4, 7, 8 and 9 -may still allow replication initiation, albeit inefficiently, due to the use of a heterologous Rep. Moreover, once initiation had occurred and the genome-sense strand had been displaced by rollingcircle synthesis, the N9 loop sequence that would reform for the ori mutant replicon ssDNA would be partly constituted by the second, unchanged ori. Thus, the mutant 5¢-TAG-GATC/CG-3¢ (cleavage site marked) would become 5¢-TAGTATT/CG-3¢, which is closer to the native geminivirus N9 and may allow more efficient ori recognition and RCR initiation for the released replicons.
An increase in copy number as determined by qPCR for the BFDV genome in planta only occurred in the presence of the BeYDV vector -however, amplification of the BeYDV replicon was obviously much more efficient than that of the BFDV form, as only a 2.5 kb linear replicon typical of BeYDV could be detected by RCA when both could have been expected to be present. Accordingly, the copy number of BFDV cp was determined using qPCR specific for BFDV cp, for the BFDV genomic clone coinfiltrated with either an empty BeYDV vector, or one containing a cloned BFDV cp. On day 4 of the experiment, the BFDV together with an empty BeYDV combination showed an approximately 100-fold amplification of the cp copy number -due to BFDV genome amplification -while the BFDV together with BeYDV-cp combination showed an approximately 1000-fold cp increase. This increase is very similar to that reported for other heterologous genes cloned into the BeYDV vector [19] , and is undoubtedly due to the BeYDV replicon amplification. The difference in replicon amplification efficiency explains what was seen for the RCA amplification, as at least 10 times more BeYDV amplicons would be present compared to BFDV.
The qPCR assay performed for the BFDV rep in plants produced an interesting result in that the amplification of rep was approximately 10-fold lower when the BeYDV replicon contained cp, compared to the empty vector. One possibility is that the BFDV CP was expressed from the plant expression vector, while it would almost certainly not be expressed from the BFDV genome due to promoter incompatibility, and it interfered in BFDV and/or BeYDV genome amplification by binding or even encapsidating the transiently ssDNA form of the genome. The possible modes of interference by CP were not tested here; however, they are the subject of ongoing investigations.
Now that we have established that it is replicationcompetent, further analysis of the viability of our synthetic BFDV genomic clone could involve the testing of infectivity in embryonated avian eggs -and preferably eggs from budgerigars, given that the virus used was isolated from this host, and we plan to use them as a model system for BFDV candidate vaccine testing. While others have tried and failed to show BFDV infection of eggs or of cultured avian cells [2] , this work was performed with purified virus and in the absence of any cell-based assay system. We contend that the use of cloned infectious genomes, and of techniques such as qPCR and RCA for accurate quantitation of genome amplification, could open up BFDV research.
The finding that the BFDV genome replicates in 293TT cells also presents an excellent opportunity for the development of a replicating BFDV-based vector for use in gene delivery to mammalian cells or even in animals, as is presently the case in plants for our BeYDV geminivirus-derived vector. The fact that BFDV has never been shown to productively infect any host but psittacines, and that it is only very distantly related to any mammal-infecting circoviruses, should mitigate concerns over inadvertent spread or recombination, should it be used as a gene vector.
The replication of the BFDV genome in N. benthamiana when coinfiltrated with our geminivirus vector was a very exciting finding, and prompted the use of the term 'xenogenic' to describe the phenomenon. The geminivirus-assisted replication could also have practical applications, as it has in the successful production of HPV-16 pseudovirions in plants in our laboratory [24] . For instance, expression in trans of the BFDV CP using a strong plant promoter could allow encapsidation of BFDV genomes for the plant-based production of either infectious virus or modified BFDV genomes. The latter case could provide a plant-based alternative gene delivery vector for psittacines or other birds, and possibly a CP/DNAbased vaccine combination that could generate both humoral and cellular immune responses.
In conclusion, we found that a synthetic partially dimeric BFDV genomic DNA clone was able to replicate once transfected into 293TT and other mammalian cells, and that it was also capable of replicating in N. benthamiana in the presence of geminivirus-derived replication elements. This is the first reported instance of a BFDV genome replicating in any cell system, and the first report of any circovirus genome replicating in plants. Both of these developments could significantly open up possibilities for making reagents and vaccines for BFDV, and possibly even sophisticated virion-based vaccines containing artificial genomes.
METHODS
Design and synthesis of the BFDV infectious molecular DNA clone The partial genome repeat of BKS1ZA_84 was synthesized in silico by Geneart (see Fig. S1 , available in the online Supplementary Material). The sequence included a 5¢ PstI and 3¢ HindIII and XbaI restriction enzyme sites for cloning purposes. The stem-loop as described by Bassami et al. [15] was identified and then confirmed through ssDNA secondary structure analysis using the mfold web server [26] (Fig. 3 ).
Cloning and mutation strategy The BFDV DNA clone was modified using PCR to disrupt either the rep or the N9 motif situated in the first stemloop. To disrupt the N9 motif the 5¢-TAGTATTAC-3¢ was mutated, and at the same time partially replaced with a BamHI restriction enzyme site for screening purposes (Fig. 1 ). An initial PCR reaction was performed using highfidelity polymerase and primers that amplified a 401 bp PCR product (Table 1 ). The thermocycling conditions were an initial denaturation at 95 C for 180 s, followed by 30 cycles of 30 s at 95 C, 30 s at 55 C and 120 s at 72 C. The amplified PCR product was resolved on 1 % (w/v) TBE agarose gel and gel-purified. A final PCR amplified a 421 bp BFDV ori PstI mutant PCR product under identical thermocycling parameters (Table 1 ). The amplified PCR product was resolved on 1 % (w/v). The gel-purified BFDV ori PstI mutant fragment was then used to replace the existing sequence through restriction enzyme digestion with PstI and SacI. The ligated constructs were transformed into competent E. coli DH5a, and the plasmid DNA was isolated from overnight cultures. The integrity of the clones was confirmed through sequencing.
To disrupt translation of the rep the ATG start codon was mutated, and at the same time replaced by a SpeI restriction enzyme site for screening purposes (Fig. 1) . Initial PCR reactions introduced the modifications and amplified a 265 bp BFDV rep SacI mutant and 239 bp BFDV rep PstI mutant PCR product ( Table 1 ). The thermocycling conditions were an initial denaturation at 95 C for 180 s, followed by 30 cycles of 15 s at 95 C, 15 s at 55 C and 45 s at 72 C. These PCR products were gel-purified and amplified together to produce a 504 bp BFDV rep SpeI mutant PCR product ( Table 1 ). The thermocycling conditions were an initial denaturation at 95 C for 180 s, followed by 30 cycles of 15 s at 95 C, 15 s at 55 C and 60 s at 72 C. The gel-purified BFDV rep SpeI mutant fragment was then used to replace the existing sequence through restriction enzyme digestion with PstI and SacI. The ligated constructs were transformed into competent E. coli DH5a, and the plasmid DNA was isolated from overnight cultures. The integrity of the clones was confirmed through sequencing. The BFDV genome constructs were then inserted into a modified pTRAc plant expression vector. The plant expression cassette of pTRAc was removed through restriction enzyme digestion with SapI and PmeI. The resulting linearized plasmid, without the plant expression cassette, contained the left and right borders for T-DNA transfer into plant cells. The linear DNA fragment was ligated together with a 30 bp DNA fragment containing a MCS with the restriction enzyme sites SapI, PstI, HindIII and PmeI ( Table 1 ). The BFDV infectious molecular DNA clones were then cloned into the modified pTRAc using PstI and HindIII. The ligated constructs were transformed into competent E. coli DH5a, and the plasmid DNA was isolated from overnight cultures. The integrity of the clones was confirmed through sequencing.
To restore RCR in the mutant rep clone, a functional rep was sub-cloned into the pTH mammalian expression vector [27] . The rep was amplified from the BFDV molecular DNA clones using a high-fidelity DNA polymerase and primers that amplified an 891 bp PCR product ( Table 1 ). The thermocycling conditions were an initial denaturation at 98 C for 30 s, followed by 40 cycles of 10 s at 98 C, 10 s at 58.7 C and 15 s at 72 C, and a final extension of 300 s at 72 C. The amplified PCR product was resolved on 0.8 % (w/v) TBE agarose gel containing 2.5 mg ml À1 ethidium bromide. The BFDV rep produce was then cloned into pTH through restriction enzyme digestion with HindIII and BamHI. The ligated construct was transformed into competent E. coli DH5a, and the plasmid DNA was isolated from an overnight culture. The integrity of the clone was confirmed through sequencing.
Transfection of 293TT cells
Endotoxin-free plasmid DNA was prepared from E. coli cultures containing the BFDV infectious molecular DNA clones. 
GGTGGTGGATCCTCAAAAATTGATGGGGTG

BamHI
The 293TT cell line was originally generated from a human embryonic kidney (HEK) cell line, 293T, that was stably transfected with an SV40 large T antigen cDNA expression cassette [28] . The 293TT cell line was maintained at 37 C in a 5 % atmospheric CO 2 and 95 % humidity incubator. The nutrient medium was exchanged every 2-3 days with DMEM, high glucose, GlutaMAX supplement, pyruvate (Life Technologies) supplemented with 10 % HyClone foetal bovine serum (South America), Research Grade (GE Healthcare), 1 % penicillin/streptomycin (100Â; SigmaAldrich), 1 % MEM non-essential amino acid (NAA) solution (100Â; Sigma-Aldrich) and 0.5 % 50 mg ml À1 hygromycin B (Roche).
A day prior to transfection, cells in 3 ml of complete growth medium (DMEM and 10 % foetal bovine serum) were plated in a six-well plate for a final density of 5Â10 5 cells per well. A FuGENEHD (Promega):DNA ratio of 3 : 1 was used for all transfections. A 931 µl solution was prepared in sterile deionized water for each BFDV infectious DNA clone at a concentration of 0.020 µg µl-1. To this, 59 µl of FuGENE HD reagent (Promega) was added, briefly vortexed and incubated for between 5-10 min at room temperature. We added 150 µl of the complex per well to the cells, mixing it thoroughly and then incubating it for 24 h. After incubation, the nutrient medium was exchanged and for day 0 cells were immediately harvested for total DNA extraction using the DNeasy blood and tissue kit (Qiagen), while the remaining cells were incubated for 3 days before being harvested.
Restoration of the RCR in the mutant rep-clone using Rep expressed from pTH-rep was performed using HEK 239T cells. A day prior to transfection cells were plated in a sixwell plate for a final density of 6Â10 5 cells per well. An X-tremGENE HP (Roche):DNA ratio of 1 : 1 (microlitre transfection reagent to microgram DNA) was used for all transfections. Transfections were then performed as per the manufacturer's instructions. For the co-transfection, the DNA plasmid mixture was prepared according to the plasmid copy number, where a 1 : 1 ratio of pTH-rep to rep-mutant plasmid was used. The results presented here are representative and were taken from one of multiple repeats.
Transfer and analysis of BFDV DNA clones in N. benthamiana BFDV DNA clones in the modified pTRAc plant shuttle vector were transformed in A. tumefaciens and then infiltrated into N. benthamiana as described by Maclean et al. [29] . Total DNA was extracted from plant leaf tissue using an Extract-N-Amp plant PCR kit (Sigma-Aldrich) on days 1-4. To enrich for circular DNA, RCA was performed on the DNA samples using an Illustra TempliPhi amplification kit (GE Healthcare) as described by Shepherd et al. [30] . The results presented here are representative and were taken from one of multiple repeats.
Quantitative real-time PCR Each qPCR reaction was performed in triplicate using a LuminoCT SYBR Green qPCR ReadyMix (Sigma-Aldrich) as per manufacturer's instructions and primers (5¢-TA TTGGTTGAGAAGCGGCGTCT-3¢ and 5¢-GACGTAGA TATGCCCGCCCAT-3¢) specific to a 96 bp region of the BFDV cp. Cloned plasmid DNA containing the amplicons in serial dilution served as the standard curve for the determination of the gene copy number for cp. Thermocycling was performed using a Rotor-Gene RG-6000 (Qiagen), and the parameters consisted of a 10 min hold at 95 C followed by cycling (40 repeats) between a 15 s hold for denaturation at 95 C, a 15 s hold at 53 C for annealing and a 15 s hold 60 C for elongation. Template specificity was confirmed from reaction melt curve analysis. In addition, BFDV rep primers (5¢-CAGTTAAGGGCGCTTTTGTGGAG-3¢ and 5¢-TTCGGGTCACAGTCCTCCTTG-3¢) specific to a 97 bp region of the BFDV rep (GenBank accession number GQ165756) were also used as describe the above with the following modifications. The annealing temperature was 55 C. SD and SEM were calculated were applicable and probability was calculated using a Student's t-test with two-tailed distribution and two-sample unequal variance.
